{"article_title": "Lilly, Merck and Valeant Receive Inquiries About Drug Pricing", "article_keywords": ["prices", "product", "seeking", "receive", "valeant", "drug", "scrutiny", "justice", "merck", "pricing", "report", "ratcheted", "lilly", "round", "inquiries", "programthe"], "article_url": "http://www.wsj.com/articles/lilly-merck-receive-inquiries-from-justice-dept-over-drug-pricing-1446828214", "article_text": "The Justice Department has ratcheted up the scrutiny of drug-pricing practices with a new round of inquiries over how pharmaceutical companies report product prices to the government Medicaid program.\n\nThe U.S. Attorney\u2019s Office for the Eastern District of Pennsylvania and the Justice Department\u2019s civil division are seeking information from Valeant Pharmaceuticals International Inc. and Eli Lilly & Co. about how they calculate and...", "article_metadata": {"article.template": "snippet", "article.created": "2015-11-06T16:43:00.000Z", "article.section": "Business", "page.region": "na,us", "page.content.type": "Article", "twitter": {"domain": "wsj.com", "description": "Drug makers Eli Lilly, Valeant and Merck have disclosed separate requests from the U.S. Justice Department for information related to drug pricing\u2014the latest sign of increased scrutiny of the industry\u2019s pricing practices.", "title": "Lilly, Merck and Valeant Receive Inquiries About Drug Pricing", "image": {"src": "https://si.wsj.net/public/resources/images/BN-LD426_ELILIL_G_20151106123956.jpg", "alt": "Lilly, Merck and Valeant receive inquiries from Justice Department over drug pricing", "identifier": "https://si.wsj.net/public/resources/images/BN-LD426_ELILIL_D_20151106123956.jpg"}, "creator": "@Loftus", "site": "@WSJ", "card": "summary_large_image"}, "al": {"ios": {"url": "wsj://launch?articleid=SB12518117221366974746504581339560053646104&headline=Lilly%2C%20Merck%20and%20Valeant%20receive%20inquiries%20from%20Justice%20Department%20over%20drug%20pricing&weburl=http://www.wsj.com/articles/SB12518117221366974746504581339560053646104"}}, "page.site.product": "WSJ", "keywords": "attorney's office,drug prices,drug pricing,eli lilly,inquiry,justice department,medicaid,merck,Eli Lilly,LLY,Merck,MRK,U.S. Justice Department,Valeant Pharmaceuticals International,VRX.T,VRX,marketing,markets,pricing,corporate,industrial news,political,general news,politics,international relations,domestic politics,government bodies,executive branch,pharmaceuticals,insurance,non-life insurance,health,medical insurance,health care,life sciences,financial services,government sponsored health insurance", "news_keywords": "attorney's office,drug prices,drug pricing,eli lilly,inquiry,justice department,medicaid,merck,Eli Lilly,LLY", "article.headline": "Lilly, Merck and Valeant receive inquiries from Justice Department over drug pricing", "cXenseParse": {"candybar": {"image": "https://si.wsj.net/public/resources/images/BN-LD426_ELILIL_E_20151106123956.jpg"}, "poptart": {"image": "https://si.wsj.net/public/resources/images/BN-LD426_ELILIL_D_20151106123956.jpg"}}, "description": "Drug makers Eli Lilly, Valeant and Merck have disclosed separate requests from the U.S. Justice Department for information related to drug pricing\u2014the latest sign of increased scrutiny of the industry\u2019s pricing practices.", "apple-itunes-app": "app-id=364387007,app-argument=wsj://launch?articleid=SB12518117221366974746504581339560053646104&headline=Lilly%2C%20Merck%20and%20Valeant%20receive%20inquiries%20from%20Justice%20Department%20over%20drug%20pricing&weburl=http://www.wsj.com/articles/SB12518117221366974746504581339560053646104", "user.type": "nonsubscriber", "testkeys": "C", "article.page": "Business", "article.summary": "Drug makers Eli Lilly, Valeant and Merck have disclosed separate requests from the U.S. Justice Department for information related to drug pricing\u2014the latest sign of increased scrutiny of the industry\u2019s pricing practices.", "page.site": "wsj", "page.content.format": "responsive", "article.published": "2015-11-06T20:49:00.000Z", "dj.asn": "i-4bd1", "robots": "noarchive,noodp", "fb": {"app_id": 368513495882}, "article": {"publisher": "https://www.facebook.com/wsj", "embed_count": 1, "image_count": 1, "word_count": 869, "internal_link_count": 4}, "viewport": "width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=no", "page.section": "Article", "language": "en-US", "og": {"site_name": "WSJ", "description": "Drug makers Eli Lilly, Valeant and Merck have disclosed separate requests from the U.S. Justice Department for information related to drug pricing\u2014the latest sign of increased scrutiny of the industry\u2019s pricing practices.", "title": "Lilly, Merck and Valeant Receive Inquiries About Drug Pricing", "url": "http://www.wsj.com/articles/lilly-merck-receive-inquiries-from-justice-dept-over-drug-pricing-1446828214", "image": {"width": 553, "identifier": "https://si.wsj.net/public/resources/images/BN-LD426_ELILIL_G_20151106123956.jpg", "height": 369}, "locale": "en_US", "type": "article"}, "author": "Peter Loftus", "article.access": "paid", "page.content.source": "WSJ Online Article", "article.origheadline": "Lilly, Merck Receive Inquiries From Justice Dept. Over Drug Pricing", "article.type": "Business", "article.id": "SB12518117221366974746504581339560053646104", "user.exp": "default", "article.updated": "2015-11-06T20:49:00.000Z"}, "article_summary": "The Justice Department has ratcheted up the scrutiny of drug-pricing practices with a new round of inquiries over how pharmaceutical companies report product prices to the government Medicaid program.\nThe U.S. Attorney\u2019s Office for the Eastern District of Pennsylvania and the Justice Department\u2019s civil division are seeking information from Valeant Pharmaceuticals International Inc. and Eli Lilly & Co. about how they calculate and..."}